In this Expert Interview, Dr. Andrew D. Seidman critically appraises the latest data, addresses the controversies, and opines about adjuvant systemic therapy for breast cancer. Medscape Hematology-Oncology
Dr. Maurie Markman reviews current data on the clinical utility of CYP2D6 testing for breast cancer patients taking tamoxifen. Medscape Genomic Medicine
This case presentation outlines the importance of effective antiemetic protection in the setting of moderately emetogenic cancer chemotherapy and highlights the challenges in achieving that goal. Medscape Hematology-Oncology
Five-year results show an absolute benefit of 9% for the combination of cetuximab and radiotherapy, compared with radiotherapy alone, in locoregional disease. Medscape Medical News
In a prospective study, intakes of meat, eggs, or dairy products were not consistently identified as risk factors for breast cancer. Medscape Medical News